|
GB607839A
(en)
|
1946-02-12 |
1948-09-06 |
Bristol Aeroplane Co Ltd |
Improvements in or relating to gas-turbine power-plants
|
|
EP0227241B1
(en)
|
1985-10-17 |
1996-09-11 |
Zeneca Inc. |
Medicinal indole and indazole keto sulphone derivatives
|
|
US5143854A
(en)
*
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
US5744101A
(en)
*
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
|
CA2081507C
(en)
|
1991-10-30 |
2004-04-06 |
Shun-Ichi Murahashi |
Process for producing epoxide
|
|
GB9127376D0
(en)
|
1991-12-24 |
1992-02-19 |
Wellcome Found |
Amidino derivatives
|
|
HU225869B1
(en)
|
1992-04-02 |
2007-11-28 |
Smithkline Beecham Corp |
Compounds with antiallergic and antiinflammatory activity and pharmaceutical compns. contg. them
|
|
WO1994021229A1
(en)
|
1993-03-17 |
1994-09-29 |
Minnesota Mining And Manufacturing Company |
Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
|
|
HUT77407A
(hu)
|
1994-06-15 |
1998-04-28 |
The Wellcome Foundation Ltd. |
(Amidino-alkil)-szulfinil- és -szulfonil-csoporttal szubsztituált aminosav-származékok, eljárás előllításukra és az ezeket tartalmazó gyógyászati készítmények
|
|
US6124334A
(en)
|
1995-02-03 |
2000-09-26 |
Pharmacia & Upjohn Company |
Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
|
|
SK281746B6
(sk)
|
1995-04-14 |
2001-07-10 |
Glaxo Wellcome Inc. |
Merací dávkovací inhalátor, neplnený merací dávkovací inhalátor a merací dávkovací inhalačný systém
|
|
MY117948A
(en)
|
1997-01-13 |
2004-08-30 |
Glaxo Group Ltd |
Nitride oxide synthase inhibitors.
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
DE19723722A1
(de)
|
1997-05-30 |
1998-12-10 |
Schering Ag |
Nichtsteroidale Gestagene
|
|
US6245804B1
(en)
|
1997-05-30 |
2001-06-12 |
Schering Aktiengesellschaft |
Nonsteroidal gestagens
|
|
TW533865U
(en)
|
1997-06-10 |
2003-05-21 |
Glaxo Group Ltd |
Dispenser for dispensing medicament and actuation indicating device
|
|
AU9281298A
(en)
|
1997-10-01 |
1999-04-23 |
Kyowa Hakko Kogyo Co. Ltd. |
Benzodioxole derivatives
|
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
|
SI1070056T1
(en)
|
1998-03-14 |
2004-12-31 |
Altana Pharma Ag |
Phthalazinone pde iii/iv inhibitors
|
|
GB9811599D0
(en)
|
1998-05-30 |
1998-07-29 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
|
DE19856475A1
(de)
|
1998-11-27 |
2000-05-31 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
US6390291B1
(en)
|
1998-12-18 |
2002-05-21 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
|
US6119853A
(en)
|
1998-12-18 |
2000-09-19 |
Glaxo Wellcome Inc. |
Method and package for storing a pressurized container containing a drug
|
|
US6315112B1
(en)
|
1998-12-18 |
2001-11-13 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
|
US6352152B1
(en)
|
1998-12-18 |
2002-03-05 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
|
CN1353717A
(zh)
|
1999-05-04 |
2002-06-12 |
莱加制药公司 |
四环黄体酮受体调节剂化合物及其方法
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
CO5180649A1
(es)
|
1999-09-01 |
2002-07-30 |
Abbott Lab |
Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
|
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
|
DE10038639A1
(de)
*
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
SK287576B6
(sk)
|
2000-08-05 |
2011-03-04 |
Glaxo Group Limited |
S-fluórmetylester kyseliny 6alfa, 9alfa-difluór-17alfa-[(2- furanylkarboxyl)oxy]-11beta-hydroxy-16alfa-metyl-3-oxo-androsta- 1,4-dién-17beta-karbotiovej, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom, jeho použitie a medziprodukty
|
|
AU2001290143A1
(en)
|
2000-09-29 |
2002-04-08 |
Glaxo Group Limited |
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
|
|
NZ525336A
(en)
*
|
2000-10-20 |
2006-03-31 |
Expression Diagnostics Inc |
Leukocyte expression profiling
|
|
GB0031179D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
|
US6484903B2
(en)
|
2001-01-09 |
2002-11-26 |
Riverwood International Corporation |
Carton with an improved dispensing feature in combination with a unique handle
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
ATE365720T1
(de)
|
2001-03-08 |
2007-07-15 |
Glaxo Group Ltd |
Agonisten von beta-adrenorezeptoren
|
|
JP4143413B2
(ja)
|
2001-03-22 |
2008-09-03 |
グラクソ グループ リミテッド |
β２−アドレナリン受容体アゴニストとしてのホルムアニリド誘導体
|
|
US20030148298A1
(en)
*
|
2001-04-03 |
2003-08-07 |
O''toole Margot |
Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof
|
|
IL158222A0
(en)
|
2001-04-30 |
2004-05-12 |
Glaxo Group Ltd |
Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha
|
|
US6905827B2
(en)
*
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
|
US7026121B1
(en)
*
|
2001-06-08 |
2006-04-11 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US7235358B2
(en)
*
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
ATE399174T1
(de)
|
2001-06-12 |
2008-07-15 |
Glaxo Group Ltd |
Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen
|
|
US7361787B2
(en)
|
2001-09-14 |
2008-04-22 |
Glaxo Group Limited |
Phenethanolamine derivatives for treatment of respiratory diseases
|
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
|
EP1467982B8
(en)
|
2002-01-14 |
2007-04-11 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
|
|
CA2473886C
(en)
|
2002-01-22 |
2012-08-21 |
The Regents Of The University Of California |
Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
|
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
|
DE60318188T2
(de)
|
2002-03-26 |
2008-12-11 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
|
|
JP2005521717A
(ja)
|
2002-03-26 |
2005-07-21 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用
|
|
US6897224B2
(en)
|
2002-04-02 |
2005-05-24 |
Schering Ag |
Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
|
|
DE10215316C1
(de)
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
|
AU2003221706B2
(en)
|
2002-04-11 |
2008-02-28 |
Merck Sharp & Dohme Corp. |
1H-Benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
|
|
EP1497261B1
(en)
|
2002-04-25 |
2007-12-19 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
SI1521733T1
(sl)
|
2002-07-08 |
2014-10-30 |
Pfizer Products Inc. |
Modulatorji glukokortikoidnega receptorja
|
|
US6995181B2
(en)
|
2002-07-18 |
2006-02-07 |
Bristol-Myers Squibb Co. |
Modulators of the glucocorticoid receptor and method
|
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
|
US7118865B2
(en)
*
|
2002-08-16 |
2006-10-10 |
Regents Of The University Of Minnesota |
Methods for diagnosing severe systemic lupus erythematosus
|
|
AU2003259747A1
(en)
|
2002-08-21 |
2004-03-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
|
CA2497550A1
(en)
|
2002-09-16 |
2004-03-25 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
|
|
GB0230045D0
(en)
|
2002-12-23 |
2003-01-29 |
Glaxo Group Ltd |
Compounds
|
|
US20050245588A1
(en)
|
2002-09-20 |
2005-11-03 |
Amjad Ali |
Octahydro-2-h-naphtho[1,2-f]indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
|
|
GB0224084D0
(en)
|
2002-10-16 |
2002-11-27 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1554264B1
(en)
|
2002-10-22 |
2007-08-08 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
|
AU2003286143A1
(en)
|
2002-10-28 |
2004-05-13 |
Glaxo Group Limited |
Phenethanolamine derivative for the treatment of respiratory diseases
|
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
|
EP2308968A1
(en)
*
|
2002-11-26 |
2011-04-13 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
AU2003297471A1
(en)
|
2003-01-03 |
2004-08-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
|
|
US20040191818A1
(en)
*
|
2003-02-26 |
2004-09-30 |
O'toole Margot Mary |
Compositions and methods for diagnosing and treating autoimmune diseases
|
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
|
EA200600148A1
(ru)
|
2003-07-01 |
2006-08-25 |
Шеринг Акциенгезельшафт |
Гетероциклически замещённые производные пентанола, способ их получения и их применение в качестве ингибиторов воспаления
|
|
US20050090559A1
(en)
*
|
2003-07-01 |
2005-04-28 |
Markus Berger |
Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents
|
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
|
UY28526A1
(es)
*
|
2003-09-24 |
2005-04-29 |
Boehringer Ingelheim Pharma |
Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
|
|
US7638515B2
(en)
|
2003-10-08 |
2009-12-29 |
Bayer Schering Pharma Aktiengesellschaft |
Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
|
|
DE10347385A1
(de)
|
2003-10-08 |
2005-05-12 |
Schering Ag |
Umgelagerte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
|
|
US7662821B2
(en)
|
2003-10-08 |
2010-02-16 |
Bayer Schering Pharma Ag |
Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
|
|
NZ546473A
(en)
|
2003-10-08 |
2009-09-25 |
Bayer Schering Pharma Ag |
1-amino-2-oxy-substituted tetrahydronaphthalene derivatives, methods for the production thereof, and their use as antiphlogistics
|
|
WO2005037811A1
(de)
|
2003-10-08 |
2005-04-28 |
Dsm Fine Chemicals Austria Nfg Gmbh & Co. Kg |
Verfahren zur herstellung chiraler substituierter epoxide
|
|
MY143366A
(en)
|
2003-10-14 |
2011-04-29 |
Glaxo Group Ltd |
Muscarinic acetylcholine receptor antagonists
|
|
ES2290769T3
(es)
|
2003-10-16 |
2008-02-16 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Sintesis estereoselectiva de ciertos alcoholes substituidos con trifluormetilo.
|
|
PT1699512E
(pt)
|
2003-11-03 |
2012-09-11 |
Glaxo Group Ltd |
Dispositivo distribuidor de fluido
|
|
PE20050489A1
(es)
|
2003-11-04 |
2005-09-02 |
Glaxo Group Ltd |
Antagonistas de receptores de acetilcolina muscarinicos
|
|
JP2007514704A
(ja)
|
2003-12-19 |
2007-06-07 |
グラクソ グループ リミテッド |
ピラゾロ［３，４−ｂ］ピリジン化合物およびホスホジエステラーゼ阻害剤としてのその使用
|
|
GB0405937D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
|
GB0405933D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
|
JP2007529486A
(ja)
|
2004-03-16 |
2007-10-25 |
グラクソ グループ リミテッド |
ピラゾロ［３，４−ｂ］ピリジン化合物、およびＰＤＥ４阻害剤としてのその使用
|
|
CA2558019A1
(en)
|
2004-03-22 |
2005-10-13 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
|
|
US7256300B2
(en)
|
2004-03-30 |
2007-08-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
|
|
US20050222154A1
(en)
|
2004-04-05 |
2005-10-06 |
Hartmut Rehwinkel |
Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
|
|
TWI363759B
(en)
|
2004-04-27 |
2012-05-11 |
Glaxo Group Ltd |
Muscarinic acetylcholine receptor antagonists
|
|
WO2006000398A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
2,3-benzoxazin derivatives as non-steroidal glucocorticoid receptor modulators
|
|
WO2006000401A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
Substituted oxazines as glucocorticoid receptor modulators
|
|
GB0418045D0
(en)
|
2004-08-12 |
2004-09-15 |
Glaxo Group Ltd |
Compounds
|
|
US7571055B2
(en)
*
|
2004-10-13 |
2009-08-04 |
Regents Of The University Of Minnesota |
Systemic lupus erythematosus
|
|
WO2006045416A1
(en)
|
2004-10-19 |
2006-05-04 |
F. Hoffmann-La Roche Ag |
Quinoline derivatives
|
|
JP5281291B2
(ja)
|
2005-01-10 |
2013-09-04 |
グラクソ グループ リミテッド |
新規化合物
|
|
US20090124588A1
(en)
|
2005-01-10 |
2009-05-14 |
Glaxo Group Limited |
Androstane 17-Alpha-Carbonate for Use in the Treatment of Inflammatory and Allergic Conditions
|
|
EP1869003B1
(en)
*
|
2005-04-14 |
2013-05-15 |
Glaxo Group Limited |
Indazoles as glucocorticoid receptor ligands
|
|
GB0620406D0
(en)
*
|
2006-10-13 |
2006-11-22 |
Glaxo Group Ltd |
Novel compounds
|